These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Bioengineering nanotechnology: towards the clinic. Zhao W; Karp JM; Ferrari M; Serda R Nanotechnology; 2011 Dec; 22(49):490201. PubMed ID: 22101146 [No Abstract] [Full Text] [Related]
24. Nanotechnology for neurodegenerative disorders. Re F; Gregori M; Masserini M Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910 [TBL] [Abstract][Full Text] [Related]
25. The growing role of nanotechnology in combating infectious disease. Blecher K; Nasir A; Friedman A Virulence; 2011; 2(5):395-401. PubMed ID: 21921677 [TBL] [Abstract][Full Text] [Related]
26. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Figuerola A; Di Corato R; Manna L; Pellegrino T Pharmacol Res; 2010 Aug; 62(2):126-43. PubMed ID: 20044004 [TBL] [Abstract][Full Text] [Related]
27. Nanotechnology for the diagnosis and treatment of diseases. Azzawi M; Seifalian A; Ahmed W Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317 [No Abstract] [Full Text] [Related]
28. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
30. Nanodelivery systems for improved topical antimicrobial therapy. Basnet P; Škalko-Basnet N Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202 [TBL] [Abstract][Full Text] [Related]
31. Nanochannel systems for personalized therapy and laboratory diagnostics. Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382 [TBL] [Abstract][Full Text] [Related]
32. [What is Nanomedicine? Nanotechnology for most of the patients!]. Müller B Rev Med Suisse; 2012 Jan; 8(325):152-3. PubMed ID: 22338491 [No Abstract] [Full Text] [Related]
33. [Targeted nanomedicine in diagnostics and therapy of neurological diseases]. Bertalan F; László B; Attila V Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015 [TBL] [Abstract][Full Text] [Related]
34. Nanomedicine in cardiovascular therapy: recent advancements. Binsalamah ZM; Paul A; Prakash S; Shum-Tim D Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635 [TBL] [Abstract][Full Text] [Related]
35. DNA Nanotechnology-Enabled Drug Delivery Systems. Hu Q; Li H; Wang L; Gu H; Fan C Chem Rev; 2019 May; 119(10):6459-6506. PubMed ID: 29465222 [TBL] [Abstract][Full Text] [Related]
36. Drug delivery: keeping tabs on nanocarriers. de la Zerda A; Gambhir SS Nat Nanotechnol; 2007 Dec; 2(12):745-6. PubMed ID: 18654423 [No Abstract] [Full Text] [Related]
37. Targeted nanosystems as therapeutic and diagnostic tools: The beautiful voyage of nanomedicine. Bottini M; Foldvari M Nanomedicine; 2016 Feb; 12(2):253-4. PubMed ID: 26707819 [No Abstract] [Full Text] [Related]
39. Eighth International Nanomedicine and Drug Delivery Symposium (NanoDDS'10). Kabanov A; Bronich T J Control Release; 2011 Jul; 153(1):1. PubMed ID: 21645563 [No Abstract] [Full Text] [Related]
40. Nanomedicine and drug delivery. Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]